Patents by Inventor Torkel Mikael Wadstrom

Torkel Mikael Wadstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
    Patent number: 5980908
    Abstract: The invention is concerned with a vaccine composition comprising an effective amount of an isolated protein derived from Staphylococcal aureus having the ability to bind fibronectin. The protein has a molecular weight of 165,000 daltons and optionally also contains a protein having a molecular weight of 87,000 daltons. The protein has the ability to elicit antibody production and a level of protein to elicit antibody production. The level of protein is sufficient to produce protection upon challenge with a Staphylococcus aureus bacterial strain in a mammal, particularly a ruminant, by forming antibodies against the Staphylococcus aureus bacterial strain.
    Type: Grant
    Filed: September 10, 1993
    Date of Patent: November 9, 1999
    Assignee: Alfa Laval AB
    Inventors: Magnus Hook, Kjell Martin Lindberg, Torkel Mikael Wadstrom
  • Fibronectin binding protein as well as its preparation
    Patent number: 5770702
    Abstract: The present invention relates to a new recombinant hybrid-DNA-molecule comprising a nucleotide sequence from S. aureus coding for a protein, or polypeptide, having fibronectin binding properties.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: June 23, 1998
    Inventors: Magnus Hook, Martin Kjell Lindberg, Lars Christer Signas, Torkel Mikael Wadstrom, Gunnar Froman